Morgan Stanley lowers FMC’s price target to $15.50 from $17, maintaining an Equal Weight rating. The firm predicts a joint venture or license agreement for FMC’s new patented molecules.

For real-time, market-moving financial news, visit TheFly. Check out today’s top-performing stocks on TipRanks.

For more information on FMC, visit TipRanks.

Read more at Yahoo Finance: FMC price target lowered to $15.50 from $17 at Morgan Stanley